Article
Tumor diversity and evolution revealed through RADseq.
Oncotarget - 27 Jun 2017
Perry Elizabeth B, Makohon-Moore Alvin, Zheng Caihong, Kaufman Charles K, Cai Jun, Iacobuzio-Donahue Christine A, White Richard M
Abstract excerpt
Cancer is an evolutionary disease, and there is increasing interest in applying tools from evolutionary biology to understand cancer progression. Restriction-site associated DNA sequencing (RADseq) was developed for the field of evolutionary genetics to study adaptation and identify evolutionary relationships among populations. Here we apply RADseq to study tumor evolution, which allows for unbiased sampling of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
